YAP1 and gastric cancer: Drugs that currently inhibit the YAP1 protein in GC include verteporfin, metformin, AICAR, and TED-347 [11–14]; however, relatively few studies have been conducted on the potential uses of YAP1-specific inhibitors in cancer.